Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review

Overview of attention for article published in Cancers, December 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 351 followers.

RT @ingentium_mel: Efficacy and Adverse Events in Metastatic #melanoma #cancer Patients Treated with Combination BRAF Plus MEK Inhibitors V…

Efficacy and Adverse Events in Metastatic #melanoma #cancer Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review. https://t.co/RitBOYYgsF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.